Migraine
Not recruitingStudy on Atogepant for Preventing Menstrual Migraine in Women
Study on Atogepant for Preventing Menstrual Migraine in Women
Italy- Participants:18–64 years
- Substances:Atogepant
- Sponsor:AbbVie Deutschland GmbH & Co. KG
Rare diseases
Investigational molecules
Locations
Back to Italy820 clinical trials in Florence, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Atogepant for Preventing Menstrual Migraine in Women
ItalyStudy on the Effects of Doxorubicin and Temozolomide After Radiotherapy in Children and Young Adults with Glioblastoma
ItalyStudy of Vosoritide for Children with Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome Not Responding to Growth Hormone
ItalyStudy to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease
ItalyStudy on Early Switching to Dolutegravir and Lamivudine for Adults with HIV-1 on Three-Drug Regimen with Virological Suppression
ItalyStudy on the Safety and Effectiveness of Methotrexate and Drug Combination for Children and Young Adults with High-Risk Metastatic Medulloblastoma
ItalyStudy on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration
ItalyStudy on Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma Not Eligible for Transplant
ItalyStudy on the Safety and Effectiveness of Timbetasin Acetate Eye Drops for Patients with Neurotrophic Keratopathy
ItalyStudy on the Effectiveness of Osimertinib for Patients with EGFR Mutant Non-Small Cell Lung Cancer Based on TP53 Mutation Status
ItalyStudy on the Effectiveness of Autologous Stem Cell Transplantation with Cytarabine in Patients with Aggressive Multiple Sclerosis
ItalyStudy on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for frontotemporal dementia, multiple sclerosis, and Dravet syndrome. Studies evaluate novel therapeutic approaches including DNL593 for FTD and frexalimab for relapsing MS.
Emphasis on safety assessment and long-term efficacy monitoring.
Comprehensive studies targeting various cancer types including colorectal cancer, breast cancer, and lung cancer. Trials explore combination therapies and novel treatment approaches.
Focus on targeted therapies and personalized treatment approaches.
Investigating treatments for psoriatic arthritis, Sjögren's syndrome, and systemic sclerosis. Research includes evaluation of new biologics and targeted therapies.
Studies aim to improve quality of life and disease management.
Studies examining treatments for COPD and respiratory infections, including evaluation of tezepelumab for moderate to severe COPD and prevention of RSV in infants.
Focus on improving respiratory outcomes and prevention strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.